A RESOLUTION celebrating the University of Kentucky Markey Cancer Center's remarkable scientific achievements.

This resolution (SR 53) is a symbolic honor from the Kentucky Senate celebrating the University of Kentucky Markey Cancer Center's scientific achievements. It specifically recognizes the Center as the first U.S. site to treat a patient with a new immunotherapy for small cell lung cancer and to launch a clinical trial for the experimental drug ZG006, which targets cancer cells using the body's immune system. The resolution highlights these milestones as part of the Center's status as an NCI-designated Comprehensive Cancer Center, offering patients access to advanced clinical trials. As a ceremonial resolution, it does not create new laws or directly affect any individuals or policies.